glp-1 receptor agonists and cancer risk in adults with obesity GLP‐1 the for cancer: A meta‐analysis of randomized controlled trials - Silverii - 2025 - Diabetes, and Metabolism GLP-1 Receptor Agonists and Cancer

these are typically mild and transient [3]

Notably, no redundant mitochondrial transporter compensates for CAC deficiency, making it indispensable for cellular life

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach

Many preclinical studies have demonstrated that the expression of key enzymes for GSH synthesis (GCL, SLC7A11, GS) and GSSG reduction-related enzymes (G6PD, NADPH, and GR) is downregulated in myocardium exposed to pathological factors [40, 43,44,45,46,47,48,49,50]

Many components found in natural products or plants have anti-inflammatory and antioxidant properties, making them excellent options for managing chronic liver disease

The main mechanism is that SY could not only reverse the decrease of antioxidant enzyme activity induced by OTA, but also protect the decrease of Bcl-2 protein level and the increase of Caspase-3 and Bax protein expression by activating Nrf2/Keap1 and PI3K/AKT signaling pathways, so as to restore normal kidney and liver conditions [112]